|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide forb36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nicholls RJ, Zinicola R and Haboubi N:
Extramural Spread of rectal cancer and the AJCC Cancer Staging
Manual 8thedition, 2017. J Ann Oncol. 30:1394–1395. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Japanese Gastric Cancer Association, .
Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric
Cancer. 20:1–19. 2017. View Article : Google Scholar
|
|
5
|
Lordick F, Mariette C, Haustermans K,
Obermannová R and Arnold D; ESMO Guidelines Committee, :
Oesophageal cancer: ESMO Clinical Practice guidelines for
diagnosis, treatment and follow-up. Ann Oncol. 27:50–57. 2016.
View Article : Google Scholar
|
|
6
|
Uemura N, Okamoto S, Yamamoto S, Matsumura
N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N and Schlemper RJ:
Helicobacter pylori infection and the development of gastric
cancer. N Engl J Med. 345:784–793. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu J, Xu BB, Zheng CH, Li P, Xie JW, Wang
JB, Lin JX, Chen QY, Truty MJ and Huang CM: Development and
external validation of a nomogram to predict recurrence free
survival after Ro resection for Stage II/III gastric cancer: An
International Multicenter Stud. Front Oncol. 10:5746112020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song Z, Wu Y, Yang J, Yang D and Fang X:
Progress in the treatment of advanced gastric cancer. Tumour Biol.
39:10104283177146262017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Edge SB, Byrd DR, Carducci MA, Greene FL
and Trotti A: AJCC Cancer Staging Manual. pp. 649Springer; New
York: 2010
|
|
10
|
Wang FH, Zhang XT, Li YF, Tang L, Qu XJ,
Ying JE, Zhang J, Sun LY, Lin RB, Qiu H, et al: The Chinese Society
of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis
and treatment of gastric cancer, 2021. Cancer Commun (Lond).
41:747–795. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bang YJ, Ruiz EY, Van Cutsem E, Lee KW,
Wyrwicz L, Schenker M, Alsina M, Ryu MH, Chung HC, Evesque L, et
al: Phase III, randomised trial of avelumab versus physician's
choice of chemotherapy as third-line treatment of patients with
advanced gastric or gastro-oesophageal junction cancer: Primary
analysis of JAVELIN Gastric 300. Ann Oncol. 29:2052–2060. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song Y, Fu Y, Xie Q, Zhu B, Wang J and
Zhang B: Anti-angiogenic agents in combination with immune
checkpoint inhibitors: A promising strategy for cancer treatment.
Front Immunol. 11:19562020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hack SP, Zhu AX and Wang Y: Augmenting
anticancer immunity through combined targeting of angiogenic and
PD-1/PD-L1 pathways: Challenges and opportunities. Front Immunol.
11:5988772020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Janjigian YY, Shitara K, Moehler M,
Garrido M, Salman P, Shen L, Wyrwicz L, Yamaguchi K, Skoczylas T,
Campos Bragagnoli A, et al: First-line nivolumab plus chemotherapy
versus chemotherapy alone for advanced gastric, gastro-oesophageal
junction, and oesophageal adenocarcinoma (CheckMate 649): A
randomised, open-label, phase 3 trial. Lancet. 398:27–40. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shitara K, Özgüroğlu M, Bang YJ, Di
Bartolomeo M, Mandalà M, Ryu MH, Fornaro L, Olesiński T, Caglevic
C, Chung HC, et al: Pembrolizumab versus paclitaxel for previously
treated, advanced gastric or gastro-oesophageal junction cancer
(KEYNOTE-061): A randomised, open-label, controlled, phase 3 trial.
Lancet. 392:123–133. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kattan MW, Karpeh MS, Mazumdar M and
Brennan MF: Postoperative nomogram for disease-specific survival
after an Ro resection for gastric carcinoma. J Clin Oncol.
21:3647–3650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song KY, Park YG, Jeon HM and Park CH: A
nomogram for predicting individual survival of patients with
gastric cancer who underwent radical surgery with extended lymph
node dissection. Gastric Cancer. 17:287–293. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lacy PD, Piccirillo JF, Merritt MG and
Zequeira MR: Head and neck squamous cell carcinoma: Better to be
young. Otolaryngol Head Neck Surg. 122:253–258. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bollschweiler E, Plum P, Mönig SP and
Hölscher AH: Current and future treatment options for esophageal
cancer in the elderly. Expert Opin Pharmacother. 18:1001–1010.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miller KD, Nogueira L, Mariotto AB,
Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL and Siegel
RL: Cancer treatment and survivorship statistics, 2019. CA Cancer J
Clin. 69:363–385. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shariat SF, Sfakianos JP, Droller MJ,
Karakiewicz PI, Meryn S and Bochner BH: The effect of age and
gender on bladder cancer: A critical review of the literature. BJU
Int. 105:300–308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nicholls RJ, Zinicola R and Haboubi N:
Extramural spread of rectal cancer and the AJCC Cancer Staging
Manual 8th edition, 2017. J Ann Oncol. 30:1394–1395. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bacigalupo R, Cudd P, Littlewood C,
Bissell P, Hawley MS and Buckley Woods H: Interventions employing
mobile technology for overweight and obesity: An early systematic
review of randomized controlled trials. Obes Rev. 14:279–2791.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wainana SM, Karomo JN, Kyalo R and Mutai
N: Using data mining techniques and R software to analyze crime
data in Kenya. Int J Data Sci Analysis. 6:202020. View Article : Google Scholar
|
|
25
|
Eom BW, Ryu KW, Nam BH, Park Y, Lee HJ,
Kim MC, Cho GS, Kim CY, Ryu SW, Shin DW, et al: Survival nomogram
for curatively resected Korean gastric cancer patients: Multicenter
retrospective analysis with external validation. PLoS One.
10:01196712015. View Article : Google Scholar
|
|
26
|
Han DS, Suh YS, Kong SH, Lee HJ, Choi Y,
Aikou S, Sano T, Park BJ, Kim WH and Yang HK: Nomogram predicting
long-term survival after d2 gastrectomy for gastric cancer. J Clin
Oncol. 30:3834–3874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hou S, Xie X, Peng Q, Zhou G, Li L, Zhou
H, Zhang G and Zhou T: Prognostic factor analysis and prognostic
model of liver metastasis of gastric cancer based on SEER database.
Chin J Gen Surg. 29:1212–1223. 2020.(In Chinese).
|
|
28
|
Shin HJ, Choi YO, Roh CK, Son SY, Hur H
and Han SU: Prediction of survival outcomes based on preoperative
clinical parameters in gastric cancer. Ann Surg Oncol.
28:7027–7037. 2021. View Article : Google Scholar : PubMed/NCBI
|
